Abstract
Background
The aim of this study is to evaluate the clinical and immunological efficacy and safety of allergen immunotherapy (AIT) in patients with allergic conjunctivitis (AC) and to compare between sublingual and subcutaneous routes of administration.
Methods
A prospective comparative case series study was performed on 100 patients with IgE-mediated AC. Patients were referred to allergy clinics for skin prick test (SPT) and AIT. Patients with positive SPT and high-serum IgE level were enrolled in this study. Patients were divided into two groups: sublingual immunotherapy (SLIT) group (50 patients) and subcutaneous immunotherapy (SCIT) group (50 patients). Both groups were followed for 1 year. Efficacy was assessed clinically by comparing pre- and post-treatment symptoms and medication scores and assessed immunologically by comparing pre- and post-treatment serum IgE level and wheal diameter of SPT. Safety of the therapy was assessed by the occurrence of adverse reactions and patient tolerability to the therapy.
Results
Patients were either mono- or polysensitized to different allergens. Aeroallergens were significantly more common than food allergens (P = 0.00). The most prevalent aeroallergens were pollens (40%) and house dust (30%). At 12-month follow-up, both routes SLIT and SCIT led to a statistically significant clinical and immunological improvement (P < 0.05). This improvement was evident in all follow-up parameters including total ocular symptom score (TOSS), medication score, total serum IgE level, and wheal diameter of skin prick test (SPT). There was no significant difference between the two routes of administration (SLIT & SCIT) in any of the follow-up parameters (P > 0.05). Patients were able to tolerate the allergen therapy without developing any serious adverse events.
Conclusion
Aeroallergen polysensitization is common among patients with AC. SPT should be included in the diagnostic workup of those patients. AIT is a safe and effective treatment option for patients with AC as it has the potential to achieve significant reduction in symptom and medication scores without ocular or systemic side effects. There is no significant difference between both routes of administration either SLIT or SCIT in achieving clinical and immunologic improvement; so the patient can choose his preferred method for therapy.
Similar content being viewed by others
References
Chigbu DI (2009) The pathophysiology of ocular allergy: a review. Cont Lens Anterior Eye:3–15
La Rosa M, Lionetti E, Reibaldi M et al (2013) Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr 14(39):18
del Cuvillo A, Sastre J, Montoro J (2009) Allergic conjunctivitis and H1 antihistamines. J Investig Allergol Clin Immunol 19:11–18
Cox L, Williams B, Sicherer S et al (2008) Pearls and pitfalls of allergy diagnostic testing: report from the American college of allergy, asthma and immunology/American academy of allergy, asthma and immunology specific IgE test task force. Ann Allergy Asthma Immunol 101:580–592
Heinzerling L, Mari A, Bergmann K-C et al (2013) The skin prick test – European standards. Clin Transl Allergy 3:3
Bacharier LB, Boner A, Carlsen KH et al (2008) Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 63:5e34
Petalas K, Durham SR (2013) Allergen immunotherapy for allergic rhinitis. Rhinology 51:99–110
Mahdy R, Nada W, Shahien E et al (2010) Hypo sensitization in the treatment of resistant cases of vernal keratoconjunctivitis. Cutan Ocul Toxicol 29:198–202
Huggins JL, Looney RJ (2004) Allergen immunotherapy. Am Fam Physician 70:689–696
Dreborg S (2001) Histamine reactivity of the skin. Allergy 56:359–364
Kapp A, Demarteau N (2006) Cost effectiveness of levocetirizine in chronic idiopathic urticaria: a pooled analysis of two randomized controlled trials. Clin Drug Investig 26:1–11
Marogna M, Spadolini I, Massolo A et al (2005) Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol 115:1184–1185
Cox L, Li JT, Nelson H et al (2007) Allergen immunotherapy: a practice parameter - second update. J Allergy Clin Immunol 120:S25–S85
SayedElah MA, Nasr N, Akr H (2015) Subcutaneous versus sublingual immunotherapy for allergic rhinitis therapy: which is superior. Int J Immunol:42–46
Williams TC et al (2013) Recognition of allergic conjunctivitis in patients with allergic rhinitis. World Allergy Organ J 6:4
Canonica GW, Baena-Cagnani CE, Bousquet J (2007) Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. Allergy 62:317–324
Almaliotis D1, Michailopoulos P, Gioulekas D et al (2013) Allergic conjunctivitis and the most common allergens in northern Greece. World Allergy Organ J 6:12
Navarro A, MD Colás C, Antón E et al (2009) Epidemiology of allergic rhinitis in allergy consultations in Spain:Alergologica 2005. J Investig Allergol Clin Immunol 19:7–13
Al-Rabia MW (2015) Food-induced immunoglobulin E-mediated allergic rhinitis. J Microsc Ultrastruct 4:69–75
Bielory L (2010) Allergic conjunctivitis and the impact of allergic rhinitis. Curr Allergy Asthma Rep 10:122–134
Ciprandi G, Cirillo I (2011) Monosensitization and polysensitization in allergic rhinitis. Eur J Intern Med 22:75–79
Popescu FD (2015) Cross-reactivity between aeroallergens and food allergens. World J Methodol 5:31–50
Ciprandi G, Alesina R, Ariano R, Aurnia P et al (2008) Characteristics of patients with allergic polysensitization: the polismail study. Eur Ann Allergy Clin Immunol 40:77–83
Fasce L, Tosca MA, Baroffio M et al (2007) Atopic infants with wheezing start always with monosensitization. All Asthma Proc 28:449–453
Ibrahim B, Abdel-Latif R (2018) Comparison between sublingual immunotherapy and subcutaneous immunotherapy in the treatment of pollen-induced vernal keratoconjunctivitis in children. Delta J Ophthalmol 19:1–8
Radtke M, Grammer L (2008) Subcutaneous administration of allergen vaccines. Clin Allergy Immunol 21:321–332
Kovesi T, Schuh S, Spier S et al (2010) Achieving control of asthma in preschoolers. CMAJ 182:172–183
Yukselen A, Kendirli S, Yilmaz M et al (2012) Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo controlled, double-blind, double-dummy study. Int Arch Allergy Immunol 157:288–298
Ishida W, Fukuda K, Harada Y et al (2014) Oral immunotherapy for allergic conjunctivitis. Cornea 33:32–36
Prakash OM, Murthy KR (1992) Immunotherapy in allergic conjunctivitis. Indian J Ophthalmol 40:9–10
Musa F, Al-Ahmad M, Arifhodzic N, Al-Herz W (2017) Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies. Hum Vaccin Immunother 13:514–517
Saporta D (2012) Efficacy of sublingual immunotherapy versus subcutaneous injection immunotherapy in allergic patients. J Environ Public Health:492–405
Mauro M, Russello M, Incorvaia C et al (2011) Birch-apple syndrome treated with birch pollen immunotherapy. Int Arch Allergy Immunol 156:416–422
Antúnez C, Mayorga C, Corzo JL et al (2008) Two-year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration. Pediatr Allergy Immunol 19:210–218
Nelson HS (2014) Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective? J Allergy Clin Immunol Pract 2:144–149
Kim KW, Kim EA, Kwon BC et al (2006) Comparison of allergic indices in monosensitized and polysensitized patients with childhood asthma. J Korean Med Sci 21:1012–1016
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in the study were in accordance with the ethical standards of institutional and national research committee and with 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study does not present any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sayed, K.M., Kamel, A.G. & Ali, A.H. One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis. Graefes Arch Clin Exp Ophthalmol 257, 1989–1996 (2019). https://doi.org/10.1007/s00417-019-04389-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-019-04389-w